Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Bone Marrow Transplant. 2022 Feb;57(2):243-251. doi: 10.1038/s41409-021-01525-1. Epub 2021 Nov 24.
We retrospectively compared the outcomes of reduced-intensity conditioning (RIC) transplantation from matched related donors (MRD; n = 266), matched unrelated donors (MUD; n = 277), and umbilical cord blood (UCB; n = 513) for mature lymphoid malignancies. The 3-year overall survival rates for the MRD, MUD, and UCB groups were 54%, 59%, and 40%, respectively (P < 0.001). Multivariate analysis showed no differences in survival between the MRD group and the MUD or UCB group. However, survival was significantly affected by the conditioning regimen and graft-versus-host disease (GVHD) prophylaxis in the UCB group, but not in the MRD and MUD groups. Notably, multivariate analysis showed that the risk of overall mortality in the UCB recipients who received the optimal conditioning regimen and GVHD prophylaxis (n = 116) was lower than that in the MRD group (relative risk [RR], 0.69; P = 0.03) and tended to be lower than that in the MUD group (RR, 0.75; P = 0.09). Our results suggest that UCB transplantation performed with the optimal conditioning regimen and GVHD prophylaxis is highly effective. Moreover, UCB is readily available. Thus, UCB transplantation with the optimal conditioning regimen and GVHD prophylaxis is preferable to MUD transplantation when MRD are not available in the setting of RIC transplantation for mature lymphoid malignancies.
亲缘全相合供者(MRD;n=266)、亲缘不全相合供者(MUD;n=277)和脐带血(UCB;n=513)。MRD、MUD 和 UCB 组的 3 年总生存率分别为 54%、59%和 40%(P<0.001)。多因素分析显示,MRD 组与 MUD 组或 UCB 组的生存无差异。然而,在 UCB 组中,生存受移植前预处理方案和移植物抗宿主病(GVHD)预防方案的影响,而在 MRD 和 MUD 组中则没有影响。值得注意的是,多因素分析显示,接受最佳预处理方案和 GVHD 预防方案的 UCB 移植受者(n=116)的总死亡率风险低于 MRD 组(相对风险 [RR],0.69;P=0.03),且倾向于低于 MUD 组(RR,0.75;P=0.09)。我们的研究结果表明,采用最佳预处理方案和 GVHD 预防方案的 UCB 移植具有较高的疗效。此外,UCB 来源广泛。因此,在接受成熟淋巴细胞恶性肿瘤的 RIC 移植治疗时,如果无法获得 MRD,与 MUD 移植相比,UCB 移植联合最佳预处理方案和 GVHD 预防方案更为可取。